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Abstract 
Giant warts are infrequent dermatological viral infections caused by Papillomavirus (HPV) 
in immune-compromised patients. Treatment may often be difficult and unsatisfactory, 
either by surgery or cytotoxic agents, because of poor immune control of viral activity in 
such hosts. Here we report on the case of a patient with advanced and persistent 
immune suppression caused by HIV disease, who developed a monstrous wart covering 
the entirety of the radial district of his right hand. He was completely healed after a long 
treatment with traditional Chinese acupuncture, in spite of minimal immune recovery 
induced by efficacious antiretroviral therapy. To the best of our knowledge, therefore, 
the present report may be the first direct clinical evidence that acupuncture may be 
effective in the treatment of cutaneous warts also in HIV-infected patients. 
 
Introduction 
Human papillomavirus (HPV) infections manifest as both cutaneous and anogenital 
diseases in HIV-infected patients [1, 2], with a variety of skin lesions, both benign and 
malignant, including common warts, epidermodysplasia verruciformis-like lesions, non-
melanoma skin cancers, and the giant condyloma of Buschke and Löwenstein (GCBL) [1]. 
The prevalence of HPV infections is significantly increased in HIV-infected patients, and 
unusual HPV types are frequently detected in this population [1, 3, 4]. Warts are often Case Rep Dermatol 2011;3:175–180 
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larger (giant wart), more numerous, more aggressive and more recalcitrant to therapy 
than those presenting in HIV-uninfected patients [1]. They represent a formidable 
therapeutic challenge, as treatment by either surgery or cytotoxic agents may be difficult 
and unsatisfactory because of poor immune control of viral activity in these patients [5–
8]. The use of traditional Chinese acupuncture has been reported in the general 
population for the treatment of several kinds of skin lesions, including warts, with 
variable success rates, although the precise mechanism of action has not been elucidated 
[9, 10]. As far as we know, this approach has never been reported for the treatment of 
warts in the context of HIV infection. 
Here we report on the case of a patient with advanced immune suppression caused by 
long-lasting HIV disease, who developed a monstrous wart covering the entirety of the 
radial district of his right hand. He was treated with an acupuncture-based approach for 
approximately 19 months, reaching complete healing of the lesions in spite of minimal 
immune recovery by antiretroviral therapy for HIV infection during the same period. 
Case Report 
A 37-year-old male drug addict was diagnosed with HIV and HCV infections in 1996; antiretroviral 
therapy was started in 1997, when his CD4 T-cell counts were 236 cells/mm
3 and his viral load was 
23,104 copies/ml. His adherence to antiretrovirals was suboptimal until 2005. He carried on a dual 
therapy with Zidovudine and Didanosine at standard doses until 1998, when he started his first Highly 
Active Antiretroviral Therapy (HAART) regimen including Stavudine, Lamivudine, Nevirapine and 
Nelfinavir. He remained with persistently low CD4 T-lymphocytes under different sequential HAART 
regimens. In June 2006, he was hospitalized in our ward due to seizures, dermatological diffuse lesions 
involving his face and neck, caused by Microsporum gypseum, and a giant wart on his right hand. He 
was first treated with i.v. liposomal Amphotericine B for his mycosis. He developed nephrotic syndrome 
with secondary anemia, which resolved after interruption of Amphotericine B. His CD4 T-cell counts 
were 72 cells/mm
3, HIV-RNA was 351,000 copies/ml. A salvage HAART regimen including Enfuvirtide, 
Tenofovir, Zidovudine, Lamivudine and Tipranavir/r was started, based on his Genotype Resistance 
Testing (GRT; RT: M41L, E44D, T67N, Y181C, L210V, T215Y; Pr: M36I, M46I, L90M, L10I, K20I, 
A71V, L63P), yielding incomplete viro-immunonological improvement; his diffuse dermatophytosis 
resolved after successful treatment with i.v. Itraconazole. 
The giant wart appeared a couple of years in advance of his hospitalization on his right hand. At the 
time of hospitalization for seizures, it had slowly and progressively covered the entire surface of the 
radial district of his right hand (fig. 1). Bleeding had been frequent in recent months, even caused by 
minimal traumas, and the patient felt this condition to be troubling and quite disabling. Approximately 
6 months in advance of hospitalization, cryotherapy had failed to reduce the extension of the lesion; a 
radical surgical approach was discarded by our consultant dermatologist because of persistent immune 
suppression by HIV. When CD4 T-cell counts were 120 cells/mm
3, a treatment based on traditional 
Chinese acupuncture was attempted, lasting for 19 months through 58 treatment sessions. For the first 2 
months, these were delivered twice weekly; in the following 4 months, they were weekly and in the 
remaining 13 months, the patient was treated once every 2 weeks. Each treatment session lasted 
approximately 30 min. According to the therapeutic principles of traditional Chinese medicine, needles 
were set at the auricle of the left ear, on the abdomen and the upper and lower limbs (table 1); further 
needles were placed at the roots of major wart elements (fig. 2). At the end of treatment, the surface of 
the right hand was completely healed, with only minimal dyschromic spots remaining over a smooth 
and fresh skin surface. CD4 T-cell count at the end of treatment was 180 cells/mm
3 (fig. 3). Case Rep Dermatol 2011;3:175–180 
DOI: 10.1159/000331427 
Published online: 
August 26, 2011 
© 2011 S. Karger AG, Basel
ISSN 1662–6567 






Giant manifestations are rare but well-recognized clinical expressions of human 
papillomaviruses. The GCBL, described by Buschke and Löwenstein in 1925, is a slow-
growing verrucous lesion affecting the penis and other districts of the anogenital region 
[11, 12]. The viral origin of these tumors led to the use of local or systemic interferon with 
moderate success, intralesional administration producing complete responses in a 
remarkable proportion of cases. The treatment of choice for GCBL and other giant 
lesions, however, is wide surgical excision, resulting in disease cure in almost half of 
patients [13–15]. Oral and topical chemotherapeutic agents were also used with variable 
success, as well as topical cidofovir in cases refractory to other conventional treatments 
[11, 12, 16, 17]. 
It is well known that subjects with persistent cell-mediated immune defects, including 
those with HIV infection, are at increased risk of persistence of both infection with and 
disease caused by Papillomaviruses, but the specific mechanisms whereby HIV-infected 
subjects develop severe cutaneous warts, including giant lesions, remain unknown [18]. 
Different explanations have been proposed [1]: first of all, a HIV-mediated direct or local 
role in HPV transcription, as well as an impaired HPV antigen presentation by depleted 
cutaneous Langerhans cells in HIV-infected patients [19, 20]. Furthermore, HIV-induced 
immune deficiency may alter the cellular immunity normally required to control HPV 
replication [1]. Recent studies focused on the different roles played by humoral and cell-
mediated immunity [18, 21]. Humoral immunity to the viral capsid of HPV has been 
shown to be sufficient for the protection against infection, while innate and adaptive cell-
mediated immunity appear important for the eradication of HPV [18]. Therefore, cell 
mediated immunity impairment caused by HIV may have a pivotal role in causing the 
spreading and difficult eradication of the wart, especially in its giant variants [18]. In the 
present case, the development of a monstrous wart covering the entirety of the radial 
district of the patient’s hand, a very different district in comparison with classical GCBL, 
took place while CD4 T-cell counts were persistently low and unresponsive to HAART. 
Our patient, with poor clinical and immune status (CD4 T-cells persistently <200 
cells/mm
3), was ineffectively treated with cryotherapy; this approach was indeed 
discontinued after a few sessions, in the evidence of inter-session overgrowth; similarly, 
invasive surgery was a priori considered inappropriate because of the size and site of his 
lesions. As a consequence, acupuncture was elected for a further trial, to help our patient 
with his serious disability, as a plausible alternative to other chemical or pharmacological 
methods for second-line treatment. Acupuncture appeared attractive at the time of its 
choice because of its potentially immune-modulating action. A number of clinical studies 
indicate its potential role in the treatment of immune-related diseases, including allergic 
disorders, and infections [22]. In our patient, however, the minimal residual T-cell 
resources seemed unlikely to support a prompt response at the extensive site of the 
lesions. Unexpectedly, acupuncture turned out to be slowly but completely efficacious, 
leaving a healthy skin surface in the end. To the best of our knowledge, therefore, the 
present report may be the first direct clinical evidence that acupuncture may be effective 
in the treatment of cutaneous warts also in HIV-infected patients, even in the extreme 
expression of giant warts in patients with severe immune depletion [10]. Case Rep Dermatol 2011;3:175–180 
DOI: 10.1159/000331427 
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Table 1. Relevant ear and body acupoints used in patient 
Acupoints  Indications according to traditional Chinese medicine 
Ear Shenmen  Mental disorders, insomnia, pain 
Kidney  Asthenia, immune deficits 
Liver  Acute and chronic liver diseases, skin diseases 
Ear acupoints 
Fingers (right ear)  Pain and dysfunction at corresponding areas of the hand, skin diseases of the hand 
CV12 – Zhong Wan  Pain, epigastric pain, abdominal distension, nausea, vomiting, insomnia 
CV10 – Xia Wan  Abdominal pain, borborygma, diarrhea 
CV6 – Qi Hai  Abdominal pain, diarrhea, oedema 
CV4 – Guan Yuan  Immune deficits, mental disorders 
PC6 – Nei Guan  Hand affections, mental disorders, febrile diseases, nausea, vomiting 
ST36 – Zu San Li  Epigastric pain, abdominal distension, nausea, vomiting, immune deficits 
Body acupoints 







Fig. 1. Giant wart covering the radial district of the patient’s right hand. 
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Fig. 3. a Patient’s hand back at the end of treatment. b Patient’s hand palm at the end of treatment. 
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